blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1646644

EP1646644 - POSH INTERACTING PROTEINS AND RELATED METHODS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.07.2008
Database last updated on 11.09.2024
Most recent event   Tooltip25.07.2008Change - representativepublished on 27.08.2008  [2008/35]
Applicant(s)For all designated states
Proteologics, Inc.
40 Ramland Road South, Suite 10
Orangeburg, NY 10962 / US
[2006/16]
Inventor(s)01 / TAGLICHT, Daniel, N.
33 Ha'Alonim St.
Lapid 73133 / IL
02 / ALROY, Iris
Hashirion Street 10/17
74065 Nes Ziona / IL
03 / REISS, Yuval
Hahavazelet 11/6
Kiriat-ono / IL
04 / YAAR, Liora
8 Kalisher Street
43354 Raanana / IL
05 / BEN-AVRAHAM, Danny
Igal Alon 20
Zichron Jackov / IL
06 / TUVIA, Shmuel
Hartzit 1
42490 Netanya / IL
07 / GREENER, Tsvika
Bilu St. 19/25
Ness Ziona 74061 / IL
 [2007/17]
Former [2006/16]01 / TAGLICHT, Daniel, N.
33 Ha'Alonim St.
Lapid 73133 / IL
02 / ALROY, Iris
Hashirion Street 10/17
74065 Nes Ziona / IL
03 / REISS, Yuval
Hahavazelet 11/6
Kiriat-ono / IL
04 / YAAR, Liora
8 Kalisher Street
43354 Raanana / IL
05 / BEN-AVRAHAM, Danny
Igal Alon 20
Zichron Jackov / IL
06 / TUVIA, Shmuel
Hartzit 1
42490 Netanya / IL
07 / GREENER, Tsvika
Hahavazelet 9a
Ness Ziona / IL
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2006/16]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date04716503.002.03.2004
[2006/16]
WO2004US06308
Priority number, dateUS20030451437P03.03.2003         Original published format: US 451437 P
US20030452284P05.03.2003         Original published format: US 452284 P
US20030455760P19.03.2003         Original published format: US 455760 P
US20030456640P20.03.2003         Original published format: US 456640 P
US20030460526P03.04.2003         Original published format: US 460526 P
US20030460792P04.04.2003         Original published format: US 460792 P
US20030464285P21.04.2003         Original published format: US 464285 P
US20030469462P09.05.2003         Original published format: US 469462 P
US20030471378P15.05.2003         Original published format: US 471378 P
US20030472327P20.05.2003         Original published format: US 472327 P
US20030474706P30.05.2003         Original published format: US 474706 P
US20030475825P03.06.2003         Original published format: US 475825 P
US20030479317P17.06.2003         Original published format: US 479317 P
US20030480215P19.06.2003         Original published format: US 480215 P
US20030480376P19.06.2003         Original published format: US 480376 P
US20030493860P08.08.2003         Original published format: US 493860 P
US20030498634P28.08.2003         Original published format: US 498634 P
US20030503931P16.09.2003         Original published format: US 503931 P
WO2003US3571210.11.2003         Original published format: PCT/US0335/712
WO2004US0360005.02.2004         Original published format: PCT/US2004/003600
[2007/08]
Former [2006/16]US20030451437P03.03.2003
US20030452284P05.03.2003
US20030455760P19.03.2003
US20030456640P20.03.2003
US20030460526P03.04.2003
US20030460792P04.04.2003
US20030464285P21.04.2003
US20030469462P09.05.2003
US20030471378P15.05.2003
US20030472327P20.05.2003
US20030474706P30.05.2003
US20030475825P03.06.2003
US20030479317P17.06.2003
US20030480215P19.06.2003
US20030480376P19.06.2003
US20030493860P08.08.2003
US20030498634P28.08.2003
US20030503931P16.09.2003
WO2003US3571210.11.2003
WO2004US0360005.02.2004
US20040549896P02.03.2004
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004078130
Date:16.09.2004
Language:EN
[2004/38]
Type: A2 Application without search report 
No.:EP1646644
Date:19.04.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 16.09.2004 takes the place of the publication of the European patent application.
[2006/16]
Search report(s)International search report - published on:US12.01.2006
(Supplementary) European search report - dispatched on:EP18.04.2007
ClassificationIPC:A61K31/515, A61K31/4015, A61K31/426, A61K31/428, A61K31/427, A61K31/341, A61P31/12, A61P31/14, C07K14/435
[2006/41]
CPC:
C12N9/93 (EP); A61K31/122 (EP); A61K31/4015 (EP);
A61K31/4166 (EP); A61K31/428 (EP); A61K31/44 (EP);
A61K31/495 (EP); A61K31/506 (EP); A61K31/7088 (EP);
A61K31/7105 (EP); A61K39/395 (EP); A61K48/00 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P31/12 (EP);
A61P31/14 (EP); C07K14/47 (EP); C12N9/00 (EP);
C12Q1/02 (EP); C12Q1/25 (EP); C12Q1/68 (EP);
C12Q1/70 (EP); C12Y603/02019 (EP); G01N33/50 (EP);
G01N33/569 (EP) (-)
Former IPC [2006/24]C07K14/00, C12N9/00, C12N15/00, C12P21/00
Former IPC [2006/16]C07K14/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/16]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:MIT POSH WECHSELWIRKENDE PROTEINE UND ENTSPRECHENDE VERFAHREN[2006/16]
English:POSH INTERACTING PROTEINS AND RELATED METHODS[2006/16]
French:PROTEINES D'INTERACTION POSH ET PROCEDES CONNEXES[2006/16]
Entry into regional phase29.09.2005National basic fee paid 
29.09.2005Search fee paid 
29.09.2005Designation fee(s) paid 
29.09.2005Examination fee paid 
Examination procedure29.09.2005Amendment by applicant (claims and/or description)
29.09.2005Examination requested  [2006/16]
06.08.2007Despatch of a communication from the examining division (Time limit: M06)
17.02.2008Application deemed to be withdrawn, date of legal effect  [2008/34]
27.03.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/34]
Fees paidRenewal fee
09.03.2006Renewal fee patent year 03
14.03.2007Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.03.200805   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO2004089302  (PROTEOLOGICS INC [US], et al) [E] 1-10* the whole document *;
 [Y]  - ACHTERBERG VAN T A, "POSH 4,A NOVEL PUTATIVE TRANSCRIPTION FACTOR, INTERACTS WITH A SPECIFIC HUMAN SPROUTY 4 ISOFORM", BLOOD, W.B.SAUNDERS COMPANY, ORLANDO, FL, US, (20011116), vol. 98, no. 11, PART 1, ISSN 0006-4971, page 823A, XP001079229 [Y] 1,3-8 * the whole document *
 [Y]  - KEANE MACCON M ET AL, "cbl-3: A new mammalian cbl family protein", ONCOGENE, (19990603), vol. 18, no. 22, ISSN 0950-9232, pages 3365 - 3375, XP002376200 [Y] 1,3-8 * abstract *

DOI:   http://dx.doi.org/10.1038/sj.onc.1202753
 [Y]  - ETTENBERG SETH A ET AL, "Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex", JOURNAL OF BIOLOGICAL CHEMISTRY, (20010720), vol. 276, no. 29, ISSN 0021-9258, pages 27677 - 27684, XP002376201 [Y] 1,3-8 * abstract *

DOI:   http://dx.doi.org/10.1074/jbc.M102641200
 [Y]  - SMIT L ET AL, "The Cbl family of signal transduction molecules", CRITICAL REVIEWS IN ONCOGENESIS 1997 UNITED STATES, (1997), vol. 8, no. 4, ISSN 0893-9675, pages 359 - 379, XP009064975 [Y] 1,3-8 * abstract *
 [A]  - JISHAGE M ET AL, "IDENTIFICATION OF TARGET GENES FOR EWS/ATF-1 CHIMERIC TRANSCRIPTION FACTOR", ONCOGENE, BASINGSTOKE, HANTS, GB, (20030109), vol. 22, no. 1, ISSN 0950-9232, pages 41 - 49, XP001152880 [A] 1,3-8 * abstract *

DOI:   http://dx.doi.org/10.1038/sj.onc.1206074
 [Y]  - KOKAME K ET AL, "HERP, A NEW UBIQUITIN-LIKE MEMBRANCE PROTEIN INDUCED BY ENDOPLASMIC RETICULUM STRESS", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, (20001020), vol. 275, no. 42, ISSN 0021-9258, pages 32846 - 32853, XP002951095 [Y] 1-10 * abstract *

DOI:   http://dx.doi.org/10.1074/jbc.M002063200
 [DY]  - SAI X ET AL, "Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid [beta]-protein", JOURNAL OF BIOLOGICAL CHEMISTRY 12 APR 2002 UNITED STATES, (20020412), vol. 277, no. 15, ISSN 0021-9258, pages 12915 - 12920, XP002426500 [DY] 1-10 * abstract *

DOI:   http://dx.doi.org/10.1074/jbc.M112372200
 [PA]  - MCKENNA S ET AL, "Energetics and specificity of interactions within Ub Uev Ubc13 human ubiquitin conjugation complexes", BIOCHEMISTRY 08 JUL 2003 UNITED STATES, (20030708), vol. 42, no. 26, ISSN 0006-2960, pages 7922 - 7930, XP002426501 [PA] 1,3-8 * abstract *

DOI:   http://dx.doi.org/10.1021/bi034480t
 [DY]  - ULRICH H D, "Protein-protein interactions within an E2-RING finger complex: Implications for ubiquitin-dependent DNA damage repair", JOURNAL OF BIOLOGICAL CHEMISTRY 28 FEB 2003 UNITED STATES, (20030228), vol. 278, no. 9, ISSN 0021-9258, pages 7051 - 7058, XP002426502 [DY] 1,3-8 * abstract *

DOI:   http://dx.doi.org/10.1074/jbc.M212195200
International search[XP]  - FIGUEROA C ET AL, "Akt2 Negatively Regulates Assembly of the POSH-MLK-JNK Signaling Complex.", THE J BIO CHEM., (20031128), vol. 278, no. 48, pages 47922 - 47927, XP002996244

DOI:   http://dx.doi.org/10.1074/jbc.M307357200
 [X]  - TAPON N ET AL, "A new Rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways.", THE EMBO JOURNAL., (1998), vol. 17, no. 5, pages 1395 - 1404, XP002250463

DOI:   http://dx.doi.org/10.1093/emboj/17.5.1395
 [X]  - XU Z ET AL, "POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis.", J EMBO., (200301), vol. 22, no. 2, pages 252 - 261, XP002985544

DOI:   http://dx.doi.org/10.1093/emboj/cdg021
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.